Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients

Journal of Viral Hepatitis

Volumn 18, Issue 1, 2011, Pages 61-69

  Miailhes, P ^a,b,c   Pradat, P ^a,b,c   Chevallier, M ^d   Lacombe, K ^e,f   Bailly, F ^a,b,c   Cotte, L ^a,b,c   Trabaud, M A ^g   Boibieux, A ^g   Bottero, J ^e,f   Trepo, C ^a,b,c   Zoulim, F ^a,b,c  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

^d Laboratoire Biomnis   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g CROIX ROUSSE HOSPITAL   (France)

Author keywords

fibrosis assessment; HIV HBV coinfection; liver biopsy; sequential algorithm; transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; EMTRICITABINE; LAMIVUDINE; TENOFOVIR;

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ELASTOGRAPHY; FATTY LIVER; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; TRANSIENT ELASTOGRAPHY;

ADULT; ALGORITHMS; BIOPSY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIV INFECTIONS; HIV-1; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 78650259306     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01275.x     Document Type: Article

References (31)

1. European Association For The Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50 (2): 227-242.
2. Moreno S, Garcia-Samaniego J, Moreno A, et al. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. J Viral Hepat 2009; 16 (4): 249-258.
3. Castera L,. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009; 16 (5): 300-314.
4. Castera L, Forns X, Alberti A,. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48 (5): 835-847. (Pubitemid 351224001)
5. Arena U, Vizzutti F, Abraldes JG, et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008; 57 (9): 1288-1293.
6. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55 (3): 403-408. (Pubitemid 43268281)
7. Fraquelli M, Rigamonti C, Casazza G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56 (7): 968-973. (Pubitemid 46999083)
8. Ganne-Carrie N, Ziol M, De Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44 (6): 1511-1517. (Pubitemid 44953656)
9. De Ledinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr (1999) 2006; 41 (2): 175-179.
10. Kirk GD, Astemborski J, Mehta SH, et al. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis 2009; 48 (7): 963-972.
11. Macias J, Recio E, Vispo E, et al. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients. J Hepatol 2008; 49 (6): 916-922.
12. Sanchez-Conde M, Montes-Ramirez ML, Miralles P, et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat (In press) 2009; Sep 2. [Epub ahead of print].
13. Vergara S, Macias J, Rivero A, et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 2007; 45 (8): 969-974. (Pubitemid 47580344)
14. Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009; 16 (1): 36-44.
15. Marcellin P, Ziol M, Bedossa P, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29 (2): 242-247. (Pubitemid 40066382)
16. Bonacini M, Louie S, Bzowej N, Wohl AR,. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004; 18 (15): 2039-2045. (Pubitemid 39463357)
17. Konopnicki D, Mocroft A, De WitS, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19 (6): 593-601. (Pubitemid 40543982)
18. Thio CL, Seaberg EC, Skolasky Jr R, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360 (9349): 1921-1926.
19. Mrani S, Chemin I, Menouar K, et al. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol 2007; 79 (8): 1075-1081. (Pubitemid 47015405)
20. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20 (1 Pt 1): 15-20.
21. Wendum D, Lacombe K, Chevallier M, et al. Histological scoring of fibrosis and activity in HIV-chronic hepatitis B related liver disease: performance of the METAVIR score assessed on virtual slides. J Clin Pathol 2009; 62 (4): 361-363.
22. Poynard T, Imbert-Bismut F, Ratziu V, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 2002; 9 (2): 128-133. (Pubitemid 36002476)
23. Seo YS, Kim ES, Kwon YD, et al. Lifer stiffness measurement in patients with chronic hepatitis B is not as useful as that in patients with chronic hepatitis C for the assessment of liver fibrosis. AASLD 2007. Hepatology 2007; 46 (4 Suppl.):842A.
24. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47 (2): 380-384. (Pubitemid 351280705)
25. Miailhes P, Pradat P, Trepo C,. Influence of aminotransferase values on liver stiffness measurement: the case of HIV-infected patients with acute viral hepatitis B or C. HIV Med 2009; 10 (1): 62-63.
26. Sagir A, Erhardt A, Schmitt M, Haussinger D,. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47 (2): 592-595. (Pubitemid 351280727)
27. Mallet VO, Dhalluin-Venier V, Verkarre V, et al. Reversibility of cirrhosis in HIV/HBV coinfection. Antivir Ther 2007; 12 (2): 279-283. (Pubitemid 46569914)
28. Bottero J, Lacombe K, Guechot J, et al. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. J Hepatol 2009; 50 (6): 1074-1083.
29. Sebastiani G, Vario A, Guido M, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006; 44 (4): 686-693.
30. Bedossa P, Dargere D, Paradis V,. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38 (6): 1449-1457. (Pubitemid 37466971)
31. Rousselet MC, Michalak S, Dupre F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41 (2): 257-264. (Pubitemid 40165369)